InterRoid Co., Ltd.
Provides the SeiRen Suite call automation solution built on an integrated STT, LLM, and TTS voice AI platform.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2012 and listed on KONEX in 2022, InterRoid specializes in Voice AI Agent technology. Based on an integrated platform combining speech-to-text (STT), large language models (LLM), and text-to-speech (TTS), it offers the SeiRen Suite call automation solution and the RAG-based chatbot builder Seiren Chatbot. Its STT engine is trained on over 25,000 hours of data, achieving a Character Error Rate (CER) of about 3.5%, and it also runs AI modeling consulting, an LLMOps platform, and AI Vision solutions.
Products & technology
- SeiRen SuiteVoice call automation combining STT, chatbot, and TTS
- Seiren ChatbotRAG+LLM+dialogue management chatbot builder platform
Regulatory approvals
data.go.kr5 Korean MFDS device approvals · 2023–2024
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-02-06Product approval · Class 3체외 제허 24-94 호
- MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-01-30Product approval · Class 4체외 제허 24-75 호
- MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-01-30Product approval · Class 4체외 제허 24-74 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2023-12-27Product approval · Class 3체외 제허 23-1181 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2023-07-28Product approval · Class 3체외 제허 23-807 호
R&D and key agreements
Source: DART corporate disclosureSTT 엔진 고도화 · STT engine trained on over 25,000 hours of data achieving a Character Error Rate of about 3.5%
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot1
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsMedical AI
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 1999 and listed on KOSDAQ in 2011, iNtRON Biotechnology develops bacteriophage-based new drugs via its itLysin and IMPA platforms alongside a molecular diagnostics business.
Founded in 1999 and listed on KONEX in 2017, Median Diagnostics develops and manufactures immunoassay, molecular, and point-of-care in vitro diagnostic kits for animal diseases.
KOSDAQ-listed precision-diagnostics company manufacturing genomic diagnostic reagents and developing related software.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition